期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
控释地诺前列酮普贝生用于引产的评价(法)
1
作者 mazouni C. Provensal m. +1 位作者 ménard j.-p. 张新艳 《世界核心医学期刊文摘(妇产科学分册)》 2006年第12期30-31,共2页
Objective:To evaluate the efficacy of cervix ripening with vaginal controlled-release Propess. Patients and methods:A retrospective study of all women who underwent cervical ripening with Propess during the study peri... Objective:To evaluate the efficacy of cervix ripening with vaginal controlled-release Propess. Patients and methods:A retrospective study of all women who underwent cervical ripening with Propess during the study period from 1st January 2002 to 31st December 2004 was carried out. A total of 130 patients who experienced Propess was compared with the next following patient who delivered spontaneously matched on gestational age. Modes of delivery,failure of labor,maternal morbidity were recorded. Results:Indications for induction of labor were:post-term pregnancies in 18.5%,pre-eclampsia in 20.8%,oligohydroamnios in 18.5%,post-term pregnancy and oligohydramnios in 10.8%,intra-uterine fetal growth in 6.9%,premature rupture of membranes in 6.9%,diminution of fetal mobility in 6.1%and miscellaneous in 11.5%. Failure of cervical ripening was 21.2%. Patients in the Propess group had a 3.5 fold higher risk of Cesarean section 95%CI:1.5-8.3; P < 0.04 . There was no case of maternal or fetal death. There was no difference in incidence of maternal complications,and post-partum haemorrhage. Discussion and conclusion:Use of vaginal pessary Propess does not induce adverse maternal or fetal morbidity. However,it was associated with a higher incidence of Cesarean delivery. 展开更多
关键词 地诺前列酮 普贝生 宫颈成熟 控释 阴道栓剂 胎儿生长迟缓 羊水过少 过期妊娠 胎膜早破 产后出血
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部